ResearcherCentral South UniversityNo recent work listed

Jingbo Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3002-9475; OpenAlex author ID A5079496360. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2023: 1 paper

Papers 1

Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Co-author DOI 10.1126/scitranslmed.adg3049 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Brent R. Stockwell · 1 shared paper, 2023 · strength 0.18
- Paper Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic … DOI 10.1126/scitranslmed.adg3049 ↗
Jiao Liu · 1 shared paper, 2023 · strength 0.18
- Paper Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic … DOI 10.1126/scitranslmed.adg3049 ↗
Xin Chen · 1 shared paper, 2023 · strength 0.18
- Paper Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic … DOI 10.1126/scitranslmed.adg3049 ↗
Rui Kang · 1 shared paper, 2023 · strength 0.18
- Paper Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic … DOI 10.1126/scitranslmed.adg3049 ↗
Daolin Tang · 1 shared paper, 2023 · strength 0.18
- Paper Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic … DOI 10.1126/scitranslmed.adg3049 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.